193 related articles for article (PubMed ID: 34880862)
1. Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer.
Zhang ZC; Guo JN; Zhang N; Wang ZQ; Lou G; Cui BB; Yang C
Front Immunol; 2021; 12():763791. PubMed ID: 34880862
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma.
Guo JN; Li MQ; Deng SH; Chen C; Ni Y; Cui BB; Liu YL
Front Oncol; 2021; 11():640196. PubMed ID: 33763372
[TBL] [Abstract][Full Text] [Related]
3. Immune-Related Genes' Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer.
Ding B; Yan W; Shen S; Meng D; Chen X; Wang S; Shen Y
Cancer Control; 2023; 30():10732748231168756. PubMed ID: 37078136
[TBL] [Abstract][Full Text] [Related]
4. An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.
Wu P; Sun W; Zhang H
Cancer Immunol Immunother; 2022 Mar; 71(3):747-759. PubMed ID: 34398303
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of prognostic immune-related genes and drug sensitivity in cervical cancer.
Pi YN; Guo JN; Lou G; Cui BB
Cancer Cell Int; 2021 Dec; 21(1):639. PubMed ID: 34852825
[TBL] [Abstract][Full Text] [Related]
6. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer.
Liu J; Chen X; Jiang Y; Cheng W
Int Immunopharmacol; 2020 Sep; 86():106735. PubMed ID: 32619957
[TBL] [Abstract][Full Text] [Related]
7. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
8. Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients.
Ke J; Liu XH; Jiang XF; He Z; Xiao J; Zheng B; Chen YF; Cai ZR; Zheng XB; Zou YF; Lan P; Wu XJ; Gao F
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e62-e70. PubMed ID: 32863096
[TBL] [Abstract][Full Text] [Related]
9. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
[No Abstract] [Full Text] [Related]
10. Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach.
Jia W; Li N; Wang J; Gong X; Ouedraogo SY; Wang Y; Zhao J; Grech G; Chen L; Zhan X
EPMA J; 2024 Jun; 15(2):375-404. PubMed ID: 38841623
[TBL] [Abstract][Full Text] [Related]
11. Identification of immune-related genes as prognostic factors in bladder cancer.
Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
[TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic immune-related genes in rhabdoid tumor of kidney based on TARGET database analysis.
Chen H; Lu S; Guan J; Zhu X; Sun F; Huang J; Zhu J; Wang J; Zhen Z; Que Y; Sun X; Zhang Y
Aging (Albany NY); 2021 Feb; 13(4):5461-5474. PubMed ID: 33588380
[TBL] [Abstract][Full Text] [Related]
13. A Novel Notch-Related Gene Signature for Prognosis and Immune Response Prediction in Ovarian Cancer.
Pi Y; Sun F; Zhang Z; Liu X; Lou G
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512088
[No Abstract] [Full Text] [Related]
14. Comprehensive analyses of glycolysis-related lncRNAs for ovarian cancer patients.
Zheng J; Guo J; Zhu L; Zhou Y; Tong J
J Ovarian Res; 2021 Sep; 14(1):124. PubMed ID: 34560889
[TBL] [Abstract][Full Text] [Related]
15. Improving ovarian cancer treatment decision using a novel risk predictive tool.
Xu Z; Song J; Cao L; Rong Z; Zhang W; He J; Li K; Hou Y
Aging (Albany NY); 2022 Apr; 14(8):3464-3483. PubMed ID: 35439731
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma.
Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q
Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696
[No Abstract] [Full Text] [Related]
17. Association between tumor mutation burden and immune infiltration in ovarian cancer.
Fan S; Gao X; Qin Q; Li H; Yuan Z; Zhao S
Int Immunopharmacol; 2020 Dec; 89(Pt A):107126. PubMed ID: 33189611
[TBL] [Abstract][Full Text] [Related]
18. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
19. Exploration and validation of the effects of robust co-expressed immune-related genes on immune infiltration patterns and prognosis in laryngeal cancer.
Zeng H; Huang Y; Chen L; Li H; Ma X
Int Immunopharmacol; 2020 Aug; 85():106622. PubMed ID: 32485354
[TBL] [Abstract][Full Text] [Related]
20. Building an Immune-Related Genes Model to Predict Treatment, Extracellular Matrix, and Prognosis of Head and Neck Squamous Cell Carcinoma.
Yang Y; Feng Y; Liu Q; Yin J; Cheng C; Fan C; Xuan C; Yang J
Mediators Inflamm; 2023; 2023():6680731. PubMed ID: 37469759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
